1/1

Export Ready

Ruxolitinib Rutinib Cream 1.5%

Name: Ruxolitinib Rutinib Cream 1.5%
SKU: 8495619
Price: 96.35 USD
Availability: InStock

Sold by BALAJI PHARMA · Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Price

₹ 96.35 /Tube

In stock

Inclusive of all taxes

Minimum order: 1 Tube

Export Snapshot

MOQ

1 Tube

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for BALAJI PHARMA.

Suitable for

Importers · Distributors · Wholesalers

Bengaluru Dispatch on request Verified seller

BALAJI PHARMA

Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

Not shared

Employees

–

GST

29AQTPJ8785C1Z2

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2019

Turnover

$250,000 - $1 MM

Incorporation Type

On request

Certifications & Awards

IMPORT EXPORT LICENSE ISSUED BY GOVERMENT OF INDIA GST ISSUED BY GOVERNMENT DRUG LICENSE ISSUED BY HEALTH AUTHORITY GOVERMENT

Product details

What are the specifications of this product?

Overview

Ruxolitinib Rutinib Cream 1.5% is a prescription topical treatment for skin conditions like eczema and vitiligo. By inhibiting JAK enzymes, it reduces inflammation and aids in skin repigmentation. Proper application as directed by a healthcare provider is essential for effectiveness and safety. This cream is produced following rigorous quality standards to ensure patient well-being.

Product Description

Ruxolitinib Rutinib Cream 1.5% is a topical medication used to treat certain skin conditions such as atopic dermatitis (eczema) and vitiligo. Ruxolitinib, the active ingredient, is a Janus kinase (JAK) inhibitor that works by modulating the immune response, thereby reducing inflammation and skin depigmentation. The cream is applied directly to the affected areas as prescribed by a healthcare professional. Patients should follow the application guidelines to achieve optimal results and minimize potential side effects. Manufactured under strict quality controls, Ruxolitinib Rutinib Cream ensures safety and effectiveness for dermatological use.

Description provided by BALAJI PHARMA.

Specifications

Concentration	1.5% Ruxolitinib
Dosage Form	Topical cream
Color and Texture	White to off-white smooth cream
Storage Conditions	Store below 25°C, protect from light and moisture
Shelf Life	Typically 24 months from manufacturing date
Manufacturer Compliance	Produced in GMP-certified facility
Usage Instructions	Apply a thin layer on affected area twice daily or as prescribed
Package Size	Available in 15g and 30g tubes

Use cases

Category	Pharmaceuticals > Dermatologicals > Topical Skin Treatments
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Tube
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ruxolitinib Rutinib Cream 1.5%. Answers compiled from verified sellers' commercial terms and platform data.

Q: What makes Ruxolitinib Rutinib Cream 1.5% different from conventional corticosteroid creams?

A: Ruxolitinib Rutinib Cream 1.5% works by selectively inhibiting JAK enzymes to modulate immune response without the side effects typically associated with corticosteroids such as skin thinning or hormonal imbalances.

Q: Is Ruxolitinib Rutinib Cream 1.5% suitable for long-term use in chronic skin conditions?

A: Yes, the cream is formulated for ongoing management under medical supervision, offering a safer profile for long-term use in conditions like vitiligo and eczema.

Q: What precautions should be taken during the use of Ruxolitinib Rutinib Cream?

A: Patients should avoid applying the cream on infected or open wounds, follow prescribed dosages, and use protective measures to avoid sun exposure on treated areas to enhance effectiveness and safety.

Q: Can Ruxolitinib Rutinib Cream 1.5% be combined with other topical treatments?

A: Combination use should only be done under healthcare provider guidance to avoid potential drug interactions or skin irritation.

Q: How should Ruxolitinib Rutinib Cream 1.5% be stored to maintain its efficacy?

A: The cream should be stored below 25°C in a dry place away from direct sunlight and moisture to preserve its stability and potency.

Question not answered? Ask sellers directly — typical response within 4 hours.